Prognostic relevance of P-cadherin expression in melanocytic skin tumours analysed by high-throughput tissue microarrays

Journal of Clinical Pathology

Volumn 59, Issue 7, 2006, Pages 699-705

  Bauer, R ^a   Wild, P J ^a   Meyer, S ^a   Bataille, F ^a   Pauer, A ^b   Klinkhammer Schalke, M ^b   Hofstaedter, F ^a   Bosserhoff, Anja K ^a  

^a UNIVERSITY OF REGENSBURG   (Germany)

^b Central Tumor Registry   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN B1; EOSIN; FORMALDEHYDE; HEMATOXYLIN; HISTONE H3; PARAFFIN; PHOSPHOHISTONE H3; UNCLASSIFIED DRUG;

ARTICLE; BREAST ADENOCARCINOMA; CANCER GRADING; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CHROMOSOME CONDENSATION; COMPUTER ASSISTED DIAGNOSIS; CONTROLLED STUDY; CORRELATION ANALYSIS; HUMAN; HUMAN TISSUE; MITOSIS INDEX; PRIORITY JOURNAL; PROGNOSIS; PROPHASE; PROTEIN PHOSPHORYLATION; RELIABILITY;

AGED; CADHERINS; CELL MEMBRANE; CYTOPLASM; DISEASE PROGRESSION; EPIDEMIOLOGIC METHODS; FEMALE; HUMANS; KI-67 ANTIGEN; MALE; MELANOMA; MIDDLE AGED; NEOPLASM PROTEINS; NEOPLASM STAGING; NEVUS, PIGMENTED; PROGNOSIS; PROTEIN ARRAY ANALYSIS; RECURRENCE; SKIN NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 33745899956     PISSN: 00219746     EISSN: None     Source Type: Journal    
DOI: 10.1136/jcp.2005.034538     Document Type: Article

References (23)

1. Wheelock MJ, Johnson KR. Cadherins as modulators of cellular phenotype. Annu Rev Cell Dev Biol 2003;19:207-35.
2. McGary EC, Lev DC, Bar-Eli M. Cellular adhesion pathways and metastatic potential of human melanoma. Cancer Biol Ther 2002;1:459-65.
3. Bogenrieder T, Herlyn M. Cell-surface proteolysis, growth factor activation and intercellular communication in the progression of melanoma. Crit Rev Oncol Hematol 2002;44:1-15.
4. Poser I, Dominguez D, de Herreros AG, et al. Loss of E-cadherin expression in melanoma cells involves up-regulation of the transcriptional repressor Snail. J Biol Chem 2001;276:24661-6.
5. Berx G, Staes K, van Hengel J, et al. Cloning and characterization of the human invasion suppressor gene E-cadherin (CDH1). Genomics 1995;26:281-9.
6. Silye R, Karayiannakis AJ, Syrigos KN, et al. E-cadherin/catenin complex in benign and malignant melanocytic lesions. J Pathol 1998;186:350-5.
7. Sanders DS, Blessing K, Hassan GA, et al. Alterations in cadherin and catenin expression during the biological progression of melanocytic tumours. Mol Pathol 1999;52:151-7.
8. Frixen UH, Behrens J, Sachs M, et al. E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 1991;113:173-85.
9. Vleminckx K, Vakaet L Jr, Mareel M, et al. Genetic manipulation of E-cadherin expression by epithelial tumor cells reveals an invasion suppressor role. Cell 1991;66:107-19.
10. Watabe M, Nagafuchi A, Tsukita S, et al. Induction of polarized cell-cell association and retardation of growth by activation of the E-cadherin-catenin adhesion system in a dispersed carcinoma line. J Cell Biol 1994;127:247-56.
11. Hoek K, Rimm DL, Williams KR, et al. Expression profiling reveals novel pathways in the transformation of melanocytes to melanomas. Cancer Res 2004;64:5270-82.
12. Wild PJ, Herr A, Wissmann C, et al. Gene expression profiling of progressive papillary noninvasive carcinomas of the urinary bladder. Clin Cancer Res 2005;11:4415-29.
13. Bauer R, Hein R, Bosserhoff AK. A secreted form of P-cadherin is expressed in malignant melanoma. Exp Cell Res 2005;305:418-26.
14. Behrmann I, Wallner S, Komyod W, et al. Characterization of methylthioadenosin phosphorylase (MTAP) expression in malignant melanoma. Am J Pathol 2003;163:683-90.
15. Pacifico MD, Grover R, Richman PI, et al. Identification of P-cadherin in primary melanoma using a tissue microarrayer: prognostic implications in a patient cohort with long-term follow up. Ann Plast Surg 2005;55:316-20.
16. Vaisanen A, Tuominen H, Kallioinen M, et al. Matrix metalloproteinase-2 (72 kD type IV collagenase) expression occurs in the early stage of human melanocytic tumour progression and may have prognostic value. J Pathol 1996;180:283-9.
17. Alonso SR, Ortiz P, Pollan M, et al. Progression in cutaneous malignant melanoma is associated with distinct expression profiles: a tissue microarray-based study. Am J Pathol 2004;164:193-203.
18. Farkas B, Hantschel M, Magyarlaki M, et al. Heat shock protein 70 membrane expression and melanoma-associated marker phenotype in primary and metastatic melanoma. Melanoma Res 2003;13:147-52.
19. Carlson JA, Slominski A, Linette GP, et al. Biomarkers in melanoma: staging, prognosis and detection of early metastases. Expert Rev Mol Diagn 2003;3:303-30.
20. Scala S, Ottaiano A, Ascierto PA, et al. Expression of CXCR4 predicts poor prognosis in patients with malignant melanoma. Clin Cancer Res 2005;11:1835-41.
21. Dai DL, Martinka M, Li G. Prognostic significance of activated Akt expression in melanoma: a clinicopathologic study of 292 cases. J Clin Oncol 2005;23:1473-82.
22. Thies A, Schachner M, Berger J, et al. The developmentally regulated neural crest-associated glycotope HNK-1 predicts metastasis in cutaneous malignant melanoma. J Pathol 2004;203:933-9.
23. Gutman M, Singh RK, Xie K, et al. Regulation of interleukin-8 expression in human melanoma cells by the organ environment. Cancer Res 1995;55:2470-5.